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The small GTPase Rac and the secondmessen-
ger cGMP (guanosine 30,50-cyclic monophos-
phate) are critical regulators of diverse cell
functions. When activated by extracellular
signals via membrane signaling receptors, Rac
executes its functions through engaging down-
stream effectors such as p21-activated kinase
(PAK), a serine/threonine protein kinase. How-
ever, the molecular mechanism by which mem-
brane signaling receptors regulate cGMP levels
is not known. Here we have uncovered a sig-
naling pathway linking Rac to the increase
of cellular cGMP. We show that Rac uses PAK
to directly activate transmembrane guanylyl
cyclases (GCs), leading to increased cellular
cGMP levels. This Rac/PAK/GC/cGMP path-
way is involved in platelet-derived growth
factor-induced fibroblast cell migration and
lamellipodium formation. Our findings connect
two important regulators of cellular physiologi-
cal functions and provide a general mechanism
for diverse receptors to modulate physiological
responses through elevating cellular cGMP
levels.
INTRODUCTION
The small GTPase Rac plays critical roles in a wide variety
of cell functions, including cell-cycle control, regulation of
gene expression, activation of NADPH oxidase of phago-
cytic cells, actin cytoskeletal reorganization, axonal guid-
ance, and cell migration (Jaffe and Hall, 2005). Rac can be
activated by extracellular signals through various types of
membrane receptors, including receptor tyrosine kinases
such as the PDGF (platelet-derived growth factor) recep-
tor. Rac executes its biological functions through activat-
ing downstream effectors. One of the best-characterized
downstream effectors of Rac is PAK (p21-activated
kinase). PAKs are a highly conserved family of serine/
threonine protein kinases (Bokoch, 2003). Nearly all
eukaryotes contain one or more PAK genes (Hofmannet al., 2004). PAK family members regulate cellular prolif-
eration, differentiation, transformation, and survival. They
also play important roles in cytoskeleton rearrangement
during cell migration. Expression of constitutively active
PAK stimulates ruffle formation and inhibits stress fibers
(Manser et al., 1997; Sells et al., 1997). Increases in PAK
expression and activity have been correlated with pro-
gression of colorectal carcinomas to metastasis (Carter
et al., 2004) and enhanced motility and invasiveness of
human breast cancer cells (Vadlamudi et al., 2000). In
mammals, PAKs can be grouped into two subfamilies:
group A (PAK1, 2, and 3) can be activated by small
GTPases such as Rac-GTP or Cdc42-GTP binding
(Bokoch, 2003). Group B (PAK4, 5, and 6) can interact
with Cdc42-GTP but are not activated by this binding.
From the crystal structure of PAK1 (Lei et al., 2000), it
appears that the inactive state is maintained by the N-
terminal autoregulatory region (residues 83–149) binding
to and inhibiting the C-terminal catalytic kinase domain.
This autoregulatory region inhibits PAK1 even when sup-
plied as an independent fragment. Binding of GTP bound
Rac (or active Cdc42) releases this inhibition. PAK1 then
autophosphorylates Thr423 in its activation loop to stabi-
lize the active state (Lei et al., 2000). In addition, PAK1,
2, and 3 can be activated by Rac/Cdc42-independent
mechanisms such as by caspase-mediated cleavage, by
membrane recruitment via adaptor proteins, and by
sphingolipids (Bokoch, 2003).
Like cAMP and Ca2+, cGMP is a ubiquitous second
messenger mediating cellular responses to various exog-
enous and endogenous signaling molecules. cGMP con-
trols diverse physiological functions such as relaxation
of vascular smooth muscles, phototransduction, epithelial
electrolyte transport, bone growth, leukocyte migration,
axonal guidance, sperm motility, platelet spreading, and
vascular permeability (Lucas et al., 2000). cGMP regulates
physiological processes by activating protein kinases,
gating specific ion channels and modulating cellular cyclic
nucleotide concentrations through phosphodiesterases
(Lucas et al., 2000). The conversion of GTP to cGMP is
catalyzed by guanylyl cyclases (GCs). There are two types
of GCs in mammals that are expressed in nearly all cell
types: the soluble and the membrane bound GCs (Lucas
et al., 2000). The soluble GCs are generally activated
when nitric oxide (NO) binds to the attached prosthetic
heme group. Seven membrane bound GCs (also namedCell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc. 341
transmembrane or particulated GCs) have been identified
in the human genome (Lucas et al., 2000). GC-A and GC-B
are natriuretic peptide receptors. GC-C can be activated
by bacterial heat-stable enterotoxins, guanylin, and uro-
guanylin. The extracellular ligands for GC-D, GC-E, GC-F,
and GC-G are not known. The activity of transmembrane
GCs can also be modulated by other receptor signals
through intracellular signaling pathways. GC-E and GC-F,
found in the retina, can be modulated by a group of reti-
nal-specific cellular proteins named GCAPs (guanylyl
cyclase activating proteins) in a calcium-dependent man-
ner (Palczewski et al., 1994). Moreover, in genetic studies
of olfaction in C. elegans, mutants defective in olfaction
sensory response have been obtained including daf-11
and odr-1, two transmembrane GCs (Birnby et al., 2000;
L’Etoile and Bargmann, 2000). Reintroduction of the intra-
cellular domain of odr-1 rescued the defective phenotype
(L’Etoile and Bargmann, 2000). Transmembrane GCs
function in regulating cell migration and actin cytoskeletal
reorganization. The sea urchin sperm membrane bound
GC is critical for sperm chemotaxis to the eggs (Bentley
et al., 1986). In addition, Dictyostelium mutants lacking
GCs are defective in cell chemotaxis (Bosgraaf et al.,
2002). Furthermore, the Drosophila transmembrane GC
Gyc76C has been genetically demonstrated to be essen-
tial for axonal guidance (Ayoob et al., 2004).
Although various types of membrane signaling recep-
tors such as growth-factor receptor tyrosine kinases can
increase cellular cGMP levels (Coffey et al., 1988; Schev-
ing et al., 1985), the molecular mechanism by which these
receptors increase cGMP is not known. Here we have dis-
covered a new signaling pathway linking the small GTPase
Rac to the increase of cellular cGMP. Our data show that
transmembrane GCs can be directly stimulated by intra-
cellular PAK kinases. Previous studies have shown that
second messengers such as cGMP and Rho-family small
GTPases such as Rac regulate cell migration and actin
cytoskeletal reorganization. However, the link between
cGMP and Rac has, until now, been missing. Our finding
bridges these two important regulators of cellular physio-
logical functions.
RESULTS
Rac Increases Cellular cGMP Levels
In our search for signal transducing molecules that could
increase the activity of GCs, we found that Rac1 could in-
crease the GC activity in cells (Figure 1A). Untransfected
CHO cells have low levels of cellular cGMP that are below
the detection limit of our method. Therefore, to reliably
measure changes of cellular cGMP, we established CHO
cell lines that stably express GC-E (CHO-GC-E cells)
(here we use GC-E as an example) (Figure S1A). Transient
expression of a constitutively activated mutant of Rac1
(Rac1G12V) in these CHO-GC-E cells led to an increase
(3-fold) of cellular cGMP levels (Figure 1A). This stimula-
tory effect is specific to Rac1 since the other two members
of the Rho-family small GTPases, RhoA and Cdc42, did342 Cell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc.not increase the cellular cGMP levels when their con-
stitutively activated mutant forms (RhoA(G14V) and
Cdc42(G12V)) were transiently expressed in CHO-GC-E
cells (Figure 1A). The lack of stimulation by RhoA and
Cdc42 was not due to poor expression of these proteins
in CHO cells (Figure 1A, bottom western blots). Further-
more, expression of RhoA(G14V) and Cdc42(G12V) in
fibroblast cells led to the formation of actin stress fibers
and filopodia, respectively (Figure S1B), indicating that
these expressed proteins were functional.
To examine whether Rac1 regulation of GC-E is exten-
sive to other GCs, we tested the effect of Rac1 on the
activity of GC-A, GC-D, GC-F, and the a1b1 soluble GC.
Rac1(G12V) was transiently expressed in cells stably
expressing GC-A, GC-D, GC-F, or soluble GC. As shown
in Figure 1B, Rac1(G12V) increased the activity of GC-A,
GC-D, and GC-F. Rac1 had no effect on the activity of
soluble GC even though the cells expressing soluble GC
responded to the soluble GC activator sodium nitroprus-
side (Figure 1B). Furthermore, neither RhoA(G14V) nor
Cdc42(G12V) had any effect on GC-D activity (Figure 1B).
These data indicate that Rac1 regulation of transmem-
brane GCs is a general phenomenon.
To verify that membrane signaling receptors could use
this Rac-mediated pathway to modulate cellular cGMP
levels, we tested PDGFR as a representative of the growth
factor receptor tyrosine kinases. In serum-starved CHO-
GC-D cells, PDGF treatment led to higher cellular cGMP
levels (Figure 1C); this increase is comparable to that
induced by Rac1(G12V) in CHO-GC-D cells (Figure 1B).
Furthermore, expression of a dominant-negative Rac1
mutant (Rac1(T17N)) blocked PDGF-induced increase of
cellular cGMP in CHO-GC-D cells (Figure 1C and
Figure S1C). In addition, cellular cGMP accumulation
was observed beginning at 1 min after PDGF treatment
(Figure 1D), similar to Rac activation by PDGF (Itoh
et al., 2002). Moreover, in Rac1-deficient mouse embry-
onic fibroblast (MEF) cells, PDGF-induced increase of
cellular cGMP was blocked (Figure 1E). Re-expression
of Rac1 in these Rac1-deficient cells restored the cGMP
response (Figure 1E). These data demonstrate that Rac
relays the PDGF signal to increase GC activity.
PAK Mediates Rac and PDGF Effect on Cellular
cGMP Levels
To understand the molecular mechanism by which Rac1
increases the activity of GCs, we studied the participation
of several downstream targets of Rac1 in this regulatory
process. We found that PAK is required for this Rac1 func-
tion (Figure 2). Transient expression of the PAK1 autoinhi-
bitory domain PAK1-(83-149), which inhibits PAK function
(Frost et al., 1998), blocked the stimulation of GC-E by
Rac1(G12V) (Figure 2A and Figure S1D). On the other
hand, expression of PAK1-(83-149)L107F, which lacks
the inhibitory effect on PAK1, did not block Rac1(G12V)-
induced cellular cGMP accumulation (Figure 2A). Further-
more, consistent with a positive role for PAK in this path-
way, we observed that expression of a constitutively
Figure 1. Rac1 Stimulates GC Activity in Cells
(A) Increase of GC-E activity by Rac1 in CHO-GC-E cells. Rac1(G12V), RhoA(G14V), CDC42(G12V), and the control vector pcDNA3 plasmid DNAs
were transiently transfected into CHO cells that stably express GC-E. Cellular cGMP levels were determined. In bottom panels, western blots show
the expression of transfected Rac1(G12V), RhoA(G14V), and Cdc42(G12V) proteins, compared to pcDNA3 vector-transfected cells.
(B) Effect of Rac1 on the activity of GC-A, GC-D, GC-F, and soluble GC. Rac1(G12V) and the control vector pcDNA3 plasmid DNAs were transiently
transfected into CHO cells stably expressing GC-A, GC-D, GC-F, or sGC (a1b1 isoform). Cellular cGMP levels were determined. In bottom panels,
western blots show the expression of transfected Rac1(G12V) proteins, compared to pcDNA3 vector-transfected cells.
(C) Dominant-negative Rac1(T17N) inhibited the stimulation of GC-D by PDGF. Plasmid DNAs for Rac1(T17N) or pcDNA3 vector were transiently
transfected into CHO-GC-D cells. Cellular cGMP levels were measured with or without PDGF stimulation (20 ng/ml for 5 min).
(D) Time course of cGMP accumulation after PDGF treatment. Data are shown as mean ± SD of three to five experiments.
(E) Rac1 deficiency blocked the stimulation of GC-D by PDGF. Rac1flox/flox cells, before or after infection of Cre-retrovirus; stably transfected with GC-
D were treated with or without PDGF (20 ng/ml for 5 min). Rac1/ + Rac1 cells were Rac1/ cells infected with retroviruses containing wild-type
Rac1. Cellular cGMP levels were measured. Error bars show mean ± SD, **, P < 0.001; *, P < 0.005; ++, P < 0.01; +, P < 0.05 (Student’s t test).active mutant of PAK1 (PAK1-(165-544)) in CHO-GC-E
cells increased the cellular cGMP levels (Figure 2B). More-
over, the participation of PAK in this modulatory process
was verified in the case of PDGF treatment in CHO-
GC-D cells (Figure 2C). Expression of the inhibitory PAK1
mutant PAK1-(83–149) was shown to block the stimulation
of GC-D activity by PDGF, while the noninhibitory mutant
PAK1-(83-149)L107F did not (Figure 2C). These findingsdemonstrate that active PAK can substitute for active
Rac1 in stimulating GC and that PAK is needed to relay
the Rac1 and PDGF signals to GC.
Direct Stimulation of GC-E by Activated PAK
To learn how PAK regulates the activity of GC-E, we
examined the possibility that GC-E activity is stimulated
directly by PAK. We purified recombinant PAK1 andCell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc. 343
Figure 2. PAK1 Is Downstream of Rac1 in the GC Stimulation Pathway
(A) Constitutively active Rac1(G12V) increased cellular cGMP levels. This Rac stimulatory effect was blocked by PAK autoinhibitory domain
(PAK1-(83-149)). A mutated PAK1-(83-149)L107F did not interfere with the Rac1(G12V) effect. Plasmid DNAs for Rac1(G12V), PAK1-(83-149),
and/or PAK1-(83-149)L107F were transiently transfected into CHO-GC-E cells. Cellular cGMP levels were measured.
(B) Constitutively active PAK (caPAK) (PAK1-(165-544)) increased GC-E activity. Plasmid DNAs for the caPAK, Rac1(G12V), and/or Rac1(T17N) were
transiently transfected into CHO-GC-E cells. Cellular cGMP levels were measured. In bottom panels, western blots show the expression of trans-
fected Rac1(G12V), Rac1(T17N), or myc-tagged PAK1-(165-544) proteins.
(C) The PAK autoinhibitory domain PAK1(83–149) blocked PDGF-induced cGMP increase in CHO-GC-D cells. The mutated PAK1-(83–149)L107F did
not interfere with the PDGF effect. Data are shown as mean ± SD of three to five experiments. **, P < 0.001 (Student’s t test).PAK2, the intracellular domain of GC-E (GC-E-intra)
and Rac1 from either Sf9 cells or E. coli (Figure 3A). Puri-
fied PAK2 (in the presence of Mg2+-ATP) by itself
increased the activity of purified GC-E-intra by 2-fold
(Figure 3B). Addition of Rac1-GTPgS to activate PAK2
led to more than an 8-fold increase of GC-E-intra activity
(Figure 3B). The stimulatory effect was due to PAK2, since
omission of PAK2 or boiled PAK2 sample had no effect on
the activity of GC-E-intra even in the presence of Rac1-
GTPgS (Figure 3B). Furthermore, similar results were
obtained with purified PAK1 (Figure 3B). Moreover, the
activation of GC-E by PAK2 (in the presence of Rac1-
GTPgS) was dose dependent with an EC50 value of
42 nM (Figure 3C). Therefore, purified PAK directly acti-
vates purified GC-E.
Phosphorylation-Independent Activation
of GC by Activated PAK
To further study the biochemical mechanism by which
PAK activates GC-E, we investigated whether PAK stimu-
lates GC through protein phosphorylation. Using in vitro
phosphorylation assays, we found that GC-E-intra was
not phosphorylated by PAK2 (with or without Rac1-
GTPgS) (Figure 4A). The purified PAK2 was catalytically
competent since it is capable of autophosphorylation,
which was enhanced by Rac1-GTPgS (Figure 4A). To344 Cell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc.rule out the possibility that purified GC-E-intra from
E. coliwas already phosphorylated, we pretreated purified
GC-E-intra with calf intestinal alkaline phosphatase. After
removal of the phosphatase by chromatography, a phos-
phorylation assay was performed, and no phosphorylation
of GC-E-intra by PAK2 was observed (Figure 4B). To
demonstrate that GC-E-intra was phosphorylatable by
a protein kinase, we showed that purified GC-E-intra
could be phosphorylated by protein kinase A (Figure S2A).
These data suggest that PAK does not work through direct
phosphorylation of GC-E.
We noticed that a PAK1 kinase-dead mutant (PAK1-
(165-544)(K298A)) could not stimulate GC-E or GC-D in
cells (Figure 4C). Furthermore, purified PAK1(K298A) or
PAK2(K278A) proteins did not activate purified GC-E-intra
with or without Rac1-GTPgS (Figure 3B). These data
suggest that the kinase activity of PAK is needed for its
stimulatory effect on GC. Since PAK does not directly
phosphorylate GC, we examined the autophosphorylation
of PAK. PAK1 can autophosphorylate itself on several
serine and threonine residues including Thr423 (Thr402
in PAK2) at the activation loop of the catalytic domain.
Phosphorylation of Thr423 is critical for the conformational
change of the activation loop, assembly of the active
configuration of the catalytic domain, and activation
of PAK1 (Lei et al., 2000). Therefore, we analyzed the
Figure 3. Direct Stimulation of Purified
GC by Purified PAK
(A) Coomassie blue staining of purified
recombinant proteins.
(B) Direct stimulation of GC-E-intra by PAK.
The activity of purified GST-GC-E-intra was
assayed in vitro in the presence or absence
of purified GST-PAK1, GST-PAK2, GST-
PAK1(K298A), GST-PAK2(K278A), and/or
Rac1-GTPgS. Data are shown as mean ± SD
of three experiments. **, P < 0.001; *, P <
0.005; ++, P < 0.01 (Student’s t test).
(C) Dose-response curve of the activation
of purified GST-GC-E-intra by purified GST-
PAK2 in the presence of Rac1-GTPgS.phosphorylation state of purified wild-type PAK2 and
PAK1 as well as the kinase-dead PAK1(K298A) or
PAK2(K278A) proteins. Western blots with antiphospho-
Thr423-PAK1/phospho-Thr402-PAK2 antibody showed
that the wild-type PAK1 and PAK2 proteins were phos-
phorylated while PAK1(K298A) and PAK2(K278A) proteins
were not (Figure 4D). To investigate whether the phos-
phorylation of PAK is essential for its ability to activate
GC, we treated the purified wild-type PAK2 protein with
alkaline phosphatase. After removing the phosphatase
through chromatography, we found that the dephos-
phorylated PAK2 could no longer activate GC-E-intra
(Figure 4E). The dephosphorylated PAK2 could still be
activated by Rac1-GTPgS in the presence of ATP leadingto Thr402 rephosphorylation; this rephosphorylated PAK2
regained its ability to stimulate GC-E-intra (Figure 4E). In
addition, we examined the effect of purified PAK2 on the
activity of purified GC-D-intra. As shown in Figure 4F,
PAK2 (in the presence of Rac1-GTPgS) increased the ac-
tivity of GC-D-intra. Although Cdc42 did not activate GC in
cells, purified PAK2 activated by purified Cdc42-GTPgS
increased GC-D-intra activity in vitro, as would be
expected (Figure 4F). It is not clear why Cdc42 does not
activate GCs via PAK in cells. One possible explanation
might be that the subcellular localization and/or duration
of PAK activated by Rac and by Cdc42 are different.
Furthermore, we mutated Thr423 of PAK1 to Glu to mimic
the autophosphorylation after activation by Rac. As shownCell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc. 345
Figure 4. Autophosphorylation of PAK Is Necessary for GC Activation by PAK
(A) PAK did not phosphorylate GC-E. Purified GST-PAK2, Rac1-GTPgS, and/or GC-E-intra-His6 were mixed as indicated. In each lane, g-
32P-ATP
was included. The positions of GST-PAK2 and GC-E-intra-His6 are indicated on the right.
(B) PAK did not phosphorylate phosphatase-pretreated GC-E.
(C) Kinase-dead PAK1 could not stimulate GC-E and GC-D in cells.346 Cell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc.
in Figure 4F, purified PAK1(K298A/T423E) significantly
increased the activity of GC-D-intra in the absence of
Rac1-GTPgS. Moreover, we used immunoprecipitated
myc-tagged PAK1 to phosphorylate GST-PAK1(K298A).
This phosphorylated PAK1(K298A) increased the activity
of GC-D-intra (Figure 4F). Therefore, although PAK does
not phosphorylate GC, its own phosphorylation is required
for its ability to activate GC.
The Kinase Domain of PAK1 Directly Interacts with
the Cyclase Domain of GC-E
Since GC-E-intra is not a substrate of PAK, we then used
five different approaches to investigate the interaction of
PAK and GC-E-intra. First, we expressed GFP-tagged
GC-E-intra and myc-tagged full-length PAK1 in HEK293
cells (Figure 5A). While an anti-GFP antibody coimmuno-
precipitated myc-PAK1 in GFP-GC-E-intra and myc-
PAK1 cotransfected cells, this antibody did not coimmu-
noprecipitate myc-PAK1 in control cells cotransfected
with GFP-GC-E-intra and myc vector, or with GFP and
myc-PAK1 (Figure 5A). Second, we examined the inter-
action of PAK and GC-E-intra in Sf9 cells (Figure 5B).
We generated recombinant baculoviruses harboring
His6-tagged GC-E-intra or GST-tagged full-length
PAK2. These recombinant baculoviruses were then
used to coinfect the Sf9 cells. Glutathione agarose beads
were used to pull down GST or GST-PAK2 from the ly-
sate. Western blots with anti-His6 antibodies revealed
that GC-E-intra only coprecipitated with GST-PAK2 but
not GST (Figure 5B). These results demonstrate that, in
both HEK293 and Sf9 cells growing in the presence of
serum (thus PAK is active), GC-E-intra forms a complex
with PAK. Third, we examined the interaction of endoge-
nous PAK and endogenous GC by using a coimmunopre-
cipitation assay. Endogenous GC-A from MEF cells was
immunoprecipitated by antibodies directed against the
C terminus of GC-A (Figure 5C). (The specificity of this
GC-A antibody was also verified in GC-A transfected
HEK293 cells [Figure S2B].) Immunoblot analysis with
anti-PAK1 antibody showed that PAK1 was found in the
immunoprecipitate obtained with anti-GC-A antibody,
but not in the immunoprecipitate obtained with control
antiserum (Figure 5C). Conversely, anti-PAK1 antibody
coimmunoprecipitated GC-A in MEF cells (Figure 5D).
These results show that PAK1 interacts with GC-A
in vivo.
Fourth, we studied the direct interaction with purified
GST-PAK2 and purified His6-tagged GC-E-intra as well
as purified His6-tagged GC-D-intra (Figures 5E and
S2C). In the absence of Rac1-GTPgS, we did not observe
any direct interaction of PAK2 and GC-E-intra (Figure 5E,lane 4). On the other hand, when Rac1-GTPgS was
included, PAK2 formed a complex with GC-E-intra, with
or without ATP (Figure 5E, lanes 2 and 3). Hence, a confor-
mation of activated PAK, which can be achieved by the
addition of Rac1-GTPgS, is needed for its interaction
with GC-E-intra. Fifth, we further characterized the inter-
action by mapping the interacting domains on both
PAK1 and GC-E (Figures 5G and 5H). We purified GST-
fusion proteins of the kinase-homology domain (residues
488–829) of GC-E (GST-GC-E-KHD) and the catalytic
cyclase domain (residues 830–1059) of GC-E (GST-GC-
E-cat). These GST-fusion proteins and the control GST
were used to pull down PAK1 from cell extracts prepared
from HEK293 cells transfected with myc-tagged full-
length PAK1, myc-tagged N-terminal regulatory domain
of PAK1 (residues 1–270), or myc-tagged PAK1 kinase
domain (residues 271–544). We found that the kinase
domain of PAK1 directly interacted with the catalytic
cyclase domain of GC-E (Figure 5H). Therefore, similar
to the allosteric activation of transmembrane adenylyl
cyclases by G proteins, PAK likely activates GC-E by
direct contact with the cyclase domain to induce a confor-
mational change.
GC Is Required for PDGF-Induced Fibroblast
Cell Migration
We then studied the physiological significance of the Rac/
cGMP signaling pathway. Since Rac1 and PAK are known
to be critical players in cell migration, although the detailed
mechanism is not completely defined (Jaffe and Hall,
2005), we reasoned that Rac1/PAK could use multiple
pathways or feedback loops to control cell migration
and that Rac1/PAK signaling through GC/cGMP is one
of them. Indeed, cGMP, the product of GCs, is known to
play a role in cell migration (Estensen et al., 1973). If that
is the case, a decrease of the GC protein levels in cells
by RNA interference should impair cell migration. We in-
vestigated this possibility in MEF cells. MEF cells mainly
express endogenous GC-A (with low levels of GC-B and
no GC-E) (Figure 6A and data not shown). While a mouse
GC-A specific siRNA reduced the protein level of GC-A,
a control siRNA did not (Figure 6A). (With a rhodamine-
labeled control siRNA, the transfection efficiency was more
than 90%.) Furthermore, the successful reduction of GC-A
protein level by RNAi was confirmed by a functional assay:
the cGMP production induced by the activation of GC-A
with the extracellular ligand atrial natriuretic peptide
(ANP) in GC-A siRNA-treated MEF cells was lower than
that in control cells (Figure 6B). Similarly, PDGF-induced
cGMP increase was reduced by GC-A siRNA treatment,
and GC-A RNAi did not induce apoptosis or inhibit cell(D) Phosphorylation state of purified PAK proteins. Purified GST-fusion proteins treated with or without calf intestinal alkaline phosphatase (CIP).
These protein samples were then separated on SDS-PAGE and western blotted with anti-phospho-Thr423-PAK1/phospho-Thr402-PAK2 antibody.
(E) Dephosphorylation of PAK abolished its stimulatory effect on GC.
(F) Purified GC-D-intra activation by purified PAK2 in the presence of purified Rac1-GTPgS or Cdc42-GTPgS. Purified PAK1(K298A/T423E) and
phosphorylated-PAK1(K298A) could also activate GC-D-intra. Data are shown as mean ± SD of three experiments. **, P < 0.001; *, P < 0.005
(Student’s t test).Cell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc. 347
Figure 5. Direct Interaction of PAK and GC-E
(A) Coimmunoprecipitation of PAK1 and GC-E in HEK293 cells. In bottom panels, anti-myc or anti-GFP antibodies were used to detect the protein
expression of transfected genes in whole-cell extracts.348 Cell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc.
proliferation during the time course of cell migration
assays (Figure 6C and data not shown).
Having successfully reduced the GC-A protein level by
RNAi, we used three different approaches to investigate
whether the reduction of GC-A protein level would inter-
fere with PDGF-induced cell migration. First, in an in vitro
wound-healing assay, while PDGF induced MEF cell
migration, the migration of GC-A siRNA-treated cells
was reduced (Figure 6D). These data demonstrated that
GC-A is important for PDGF-induced cell migration. Sec-
ond, we further confirmed the role of GC in PDGF-induced
cell migration by Boyden chamber assay (Figure 6E).
Similar results were observed when a second different
siRNA against GC-A was used (Figures S3A and S3B).
Furthermore, PDGF-induced MEF cell migration depends
on Rac and PAK since expression of dominant-negative
Rac1(T17N) and PAK1-(83–149) proteins reduced the
cell migration (Figures 6D and 6E). Moreover, re-expres-
sion of human GC-A in mouse GC-A siRNA-treated MEF
cells rescued the PDGF-induced cell migration (there are
six nucleotide mismatches between mouse and human
GC-As in the sequence against which the siRNA was
designed) (Figure 6F). In addition, GC-A siRNA inhibited
Rac1(G12V)-induced cell migration (Figure 6G). Also, ex-
pression of dominant-negative PAK1-(83–149) proteins
reduced Rac1(G12V)-induced cell migration (Figure 6G).
Moreover, expression of constitutively active Rac1(G12V)
or PAK1-(165-544) increased cellular cGMP levels in MEF
cells and in HeLa cells (Figure 6H). Additionally, from time-
lapse recordings, control siRNA-treated MEF cells mi-
grated in response to PDGF (Figure 6I and Movie S1).
On the other hand, most GC-A siRNA-treated cells did
not move much (Figure 6I and Movies S2 and S3). ANP
treatment alone or expression of constitutively active
PAK alone was not sufficient to induce MEF cell migration,
and dominant-negative mutants of Rac1 and PAK1 did not
interfere with the direct activation of GC-A by ANP (data
not shown). Thus, an increased cGMP level (or a gradient)
is required, but by itself not sufficient, for cell migration.
Together, these data show that GCs, like Rac and PAK,
play a critical role in cell migration.
Role of GC in PDGF-Induced Lamellipodium
Formation
To further explore the molecular mechanism by which GC
is required for PDGF-induced fibroblast cell migration, westudied the potential role for the Rac/cGMP pathway in
lamellipodium formation. Lamellipodia are protruding
membrane structures at the leading edge of migrating
cells. Rac1 and PAK have been shown to mediate PDGF-
induced lamellipodium formation (Ridley et al., 1992; Sells
et al., 1999). We thus investigated whether the Rac/cGMP
pathway is involved in lamellipodium formation. As shown
in Figures 7A and 7B, migrating MEF cells (treated with
a control siRNA) at the edge of a wound in the presence
of PDGF displayed lamellipodia (85% of the cells). Sig-
nificantly, GC-A siRNA treatment led to the reduction of
lamellipodia in the presence of PDGF (25% of cells
with lamellipodia). Furthermore, expression of constitu-
tively active HA-tagged Rac1(G12V) induced the forma-
tion of lamellipodia or membrane ruffles (in 100% of
infected cells) (Figures 7C and 7D). The infected cells
were identified by immunostaining with the anti-HA
antibody (shown in the inserts of the figures). This effect
was inhibited by GC-A RNAi treatment (only 10% of
Rac1(G12V)-infected cells displayed lamellipodia) (Fig-
ure 7C and 7D). Moreover, although ANP alone was not
sufficient to induce MEF cell migration, it induced transient
formation of lamellipodia (Figure 7E). These data suggest
that GC is involved in PDGF- and Rac1-induced lamellipo-
dium formation.
We also investigated the potential effect of GC on cell
polarity. In the presence of PDGF, cells at the wound
edge become polarized and extend a long protrusion
into the wound. The microtubule organizing center
(MTOC) (stained with anti-pericentrin antibodies) and the
microtubule cytoskeleton (stained with anti-tubulin anti-
bodies) reorganize to face the wound (Etienne-Manneville
and Hall, 2001) (Figure 7F). GC-A RNAi did not affect the
cell polarity. In both control siRNA-treated cells and GC-
A siRNA-treated cells, PDGF induced 60–70% of cells
in the front row to exhibit a polarized MTOC (Figure 7G).
In the absence of PDGF, random orientation of the
MTOC facing the wound corresponds to 30% of cells
(Figure 7G). Therefore, GC-A RNAi did not prevent the for-
mation of protrusions and the polarization of the MTOC.
DISCUSSION
We have uncovered a new cellular signaling pathway that
links the small GTPase Rac and the second messenger
cGMP (Figure 7H). Since Rac and PAK have been linked(B) Coimmunoprecipitation of PAK2 and GC-E in Sf9 cells.
(C) PAK1 interacts with GC-A in vivo. Whole-cell lysates (MEF cells transfected with Rac1(G12V) to activate endogenous PAK) were subjected to im-
munoprecipitation with anti-GC-A antibody, and immunoprecipitated proteins were analyzed by immunoblotting with anti-PAK1 antibody.
(D) Anti-PAK1 antibody coimmunoprecipitated GC-A from MEF cells. Conditions were the same as in (C).
(E and F) Interaction of purified PAK with purified GC-E in the presence of Rac-GTPgS.
(G) In the left panel, Coomassie staining of purified GST-GC-E-KHD (the kinase homology domain, residues 488–829), GST-GC-E-cat (the catalytic
cyclase domain, residues 830–1059), or GST proteins used in the interaction assays is shown. In the right panel, western blot with anti-myc antibody
to show the expression of transfected myc-PAK1-N (residues 1–270), myc-PAK1-KD (residues 271–544), and myc-PAK1 in HEK293 cells used for the
interaction assays is shown.
(H) Interaction of GC-E and PAK1. Purified GST, GST-GC-E-cat, or GST-GC-E-KHD proteins were mixed with lysates from HEK293 cells transfected
with myc-PAK1-N, myc-PAK1-KD, or myc-PAK1. Data are representative of three to four similar experiments.Cell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc. 349
Figure 6. Role of GC-A in PDGF-Induced Cell Migration
(A) Western blot with anti-GC-A antibody showing the reduction of GC-A protein levels in GC-A siRNA cells compared to cells treated with a control
siRNA. In bottom panels, western blots with anti-tubulin, anti-Rac1, or anti-PAK1 antibodies show no changes in control and GC-A siRNA cells.
(B) ANP-induced accumulation of cellular cGMP was reduced in GC-A siRNA cells compared to cells transfected with a control siRNA.
(C) GC-A siRNA treatment reduced the cGMP levels induced by PDGF, compared to cells treated with a control siRNA.
(D) GC-A siRNA treatment, expression of dominant-negative Rac1(T17N) or PAK1-(83–149) reduced the cell migration induced by PDGF in a wound-
healing assay.
(E) GC-A siRNA treatment and expression of dominant-negative Rac1 or PAK1 mutant proteins reduced the cell migration induced by PDGF in a Boy-
den chamber assay.
(F) Re-expression of human GC-A in MEF cells treated with mouse GC-A siRNA rescued the cell migration induced by PDGF.
(G) GC-A siRNA treatment and expression of dominant-negative PAK1 mutant proteins reduced Rac1(G12V)-induced cell migration.
(H) Expression of constitutively active Rac1(G12V) or PAK1-(165-544) increased the endogenous cGMP levels in MEF cells and HeLa cells.
(I) Time-lapse recordings of MEF cells treated with a control siRNA or GC-A siRNA. The position of cells at 0 min (before PDGF addition) was marked
as red. The position of cells at 3 hr was marked as green. Data are representative of three to four similar experiments. **, P < 0.001; *, P < 0.005; ++,
P < 0.01 (Student’s t test).350 Cell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc.
to various receptor signaling, this new Rac/PAK/GC/
cGMP pathway could provide a general mechanism for
various types of signaling receptors to increase the cellu-
lar concentrations of cGMP. We have shown here that
PAK directly increases the activity of purified GC. Other
purified protein kinases including PKC, PKA, Src, Abl, or
Csk had no effect on the activity of GC-E or GC-D in vitro
(unpublished data), suggesting that the effect on GCs is
rather specific to PAK kinases. PAK does not phosphory-
late GC. Rather, PAK contacts the cyclase domain of GC,
likely causing a conformational change and activation of
GC. This allosteric mechanism (direct contact and confor-
mational change) is similar to the proposed mechanisms
for the activation of membrane bound GCs by their ligands
such as ANP, of soluble GCs by NO, and adenylyl cy-
clases by heterotrimeric G proteins (Lucas et al., 2000;
Tesmer et al., 1997).
The phosphorylation-independent function of PAK1 has
been described before, although the molecular mecha-
nism was not known (Bokoch, 2003; Daniels et al., 1998;
Frost et al., 1998; Sells et al., 1997). For example, PAK1 in-
duces lamellipodium formation and membrane ruffling in
fibroblasts and neurite outgrowth in PC12 cells, indepen-
dent of its catalytic activity (Daniels et al., 1998; Frost
et al., 1998). Furthermore, a recent crystal structure of
the dimer of the kinase domain of EGFR could provide a po-
tential structural basis for how the PAK kinase domain allo-
sterically activates GCs (Zhang et al., 2006). In this asym-
metric dimer of the EGFR kinase domain, one kinase
domain (using its C-terminal lobe) allosterically activates
the second kinase domain (by contacting the N-terminal
lobe and changing the conformation of the active site of
the second kinase domain into the active state) (Zhang
et al., 2006). This activation does not involve the phosphor-
ylation of one kinase domain by the other kinase domain.
The first kinase domain acts as an allosteric activator.
Transmembrane GCs could serve dual roles to increase
cellular cGMP levels to different degrees, thus leading to
possible different, sometimes opposing, physiological
effects. Extracellular ligands such as ANP bind to trans-
membrane GCs and activate their cyclase activity leading
to 100- to 1000-fold increase of cellular cGMP levels.
On the other hand, growth-factor receptors and other
membrane receptors could use the Rac/cGMP pathway
or the GCAP proteins in retinal cells to stimulate the cyclase
activity of transmembrane GCs from the interior of the cell
leading to 3- to10-fold increase of cellular cGMP levels.
As the effect of cGMP on physiological processes is depen-
dent on cGMP concentrations (Elferink and VanUffelen,
1996), it is conceivable that activation of transmembrane
GCs by growth factors and by ligands such as ANP could
lead to different responses, depending on the cell type
and the spatio-temporal dynamics of cGMP in living cells.
PAKs regulate a variety of physiological processes such
as cell migration, morphological changes, gene expres-
sion, cell proliferation, and differentiation. Here we have
shown that the PAK/GC/cGMP pathway is part of the reg-
ulatory mechanism by which PDGF induces fibroblast cellmigration. The molecular mechanism of action of cGMP in
cell migration is still poorly understood. One of the major
targets of cGMP is cGMP-dependent protein kinase
(PKG). A major substrate of PKG is VASP (vasodilator-
stimulated phosphoprotein). Cells overexpressing VASP
have lamellipodia that protrude faster than control cells,
but these protrusions are rapidly withdrawn (Krause
et al., 2003). Thus, VASP increases lamellipodium protru-
sion velocity but has an overall negative effect on whole-
cell motility (Krause et al., 2003). PKG phosphorylation of
VASP is proposed to relieve this negative effect on cell mi-
gration (Krause et al., 2003). There are other potential tar-
gets for cGMP in regulating cell migration. cGMP could
regulate Ca2+ influx, intracellular Ca2+ concentration, myo-
sin phosphatase activation, and myosin phosphorylation
(Sauzeau et al., 2000; Schlossmann et al., 2000; Surks
et al., 1999). Furthermore, cGMP could positively regulate
the activity of Rac and PAK, forming a positive feedback
loop. 8-Br-cGMP, through PKG, could activate Rac and
PAK in HEK293 cells (Hou et al., 2004). Although PKG did
not directly phosphorylate Rac, they colocalize on mem-
brane ruffles (Hou et al., 2004). This feedback regulation
might be one of the many feedback loops that are essential
for the repetitive behavior of cell migration.
The new Rac/cGMP pathway might have implications
for studies on axonal guidance. The control of actin cyto-
skeletal reorganization lies at the core of axon guidance.
Rho-family GTPases play a key role in transmitting extra-
cellular signals to changes in actin cytoskeletal structure
and motility in growth cones. In Drosophila photoreceptor
axonal guidance, both Rac and PAK have been genetically
demonstrated to play critical roles (Hing et al., 1999;
Newsomeet al., 2000). However, thedownstreamsignaling
molecules have not yet been defined. On the other hand, in
Xenopus spinal neurons and rat sensory neurons, the ratio
of cAMP/cGMP is important in axonal guidance, yet the
upstream signaling components modulating the cyclic
nucleotide levels within neurons are not clear (Nishiyama
et al., 2003; Song et al., 1998). Furthermore, theDrosophila
transmembrane GC Gyc76C is essential for motor axon
guidance downstream of Semaphorin-1a-Plexin A signal-
ing (Ayoob et al., 2004). Moreover, mouse genetic studies
have shown that cGMP-mediated signaling through PKG
is required for spinal cord sensory neuron guidance and
connectivity (Schmidt et al., 2002). Our finding that Rac/
PAK regulates GC/cGMP provides new insights that could
potentially unify these seemingly different axonal guidance
pathways. Moreover, our discovery of the Rac/PAK/GC/
cGMP pathway opens the way for further studies on the
role of cGMP in Rac/PAK signaling and of Rac/PAK in
cGMP signaling in various biological processes.
EXPERIMENTAL PROCEDURES
Cell Culture and Coimmunoprecipitation
CHO-GC cells were generated by stably transfecting CHO-K1 cells
with plasmids encoding GCs. CHO-K1 cells were cultured in F12K
nutrient mixture (Kaighn’s modification) containing 10% fetal bovineCell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc. 351
Figure 7. GC-A Is Required for PDGF-Induced Lamellipodium Formation
(A) PDGF (20 ng/ml for 30 min) induced the formation of lamellipodia (indicated by arrowheads) in control siRNA-treated cells at the edge of the wound.
GC-A siRNA treatment blocked PDGF-induced lamellipodium formation. Data are representative of three to four similar experiments.
(B) Quantification of the data from experiments in (A).352 Cell 128, 341–355, January 26, 2007 ª2007 Elsevier Inc.
serum (Invitrogen). Transfections of CHO-K1 cells were performed
with Transfast (Promega). HEK293 cells were maintained in Dulbec-
co’s modified Eagle’s medium containing 10% fetal bovine serum.
Transfections of HEK293 cells were performed using either calcium
phosphate or Lipofectamine2000 (Invitrogen). MEF cells were routinely
cultured in Dulbecco’s modified Eagle’s medium containing 10% fetal
bovine serum.
Generation of Rac1-deficient cells from Rac1flox/flox mice has been
described before (Gu et al., 2003; Guo et al., 2006). MEF cells isolated
from E13.5 Rac1flox/flox mouse embryos were transduced with MIEG3-
Cre retroviruses (with IRES-EGFP). EGFP+ cells were isolated using an
FACS sorter. Deficiency of Rac1 was verified by western blot analysis
with anti-Rac1 monoclonal antibody (Upstate Biotechnology). GC-D
was transfected into these cells. For the re-expression of Rac1, retro-
viruses containing Rac1 were used to infect Rac1/ MEF cells.
Coimmunoprecipitations and western blots were performed as
previously described (Ma et al., 2000; Wan et al., 1996). For the
coimmunoprecipitation experiments of PAK1 and GC-A, anti-GC-A
antibody was from FabGennix, Inc. International (Shreveprot, LA)
(Cat. # PGCA-100). Anti-PAK1 antibody was from Cell Signaling Tech-
nology (MA) (Cat. # 2602). The anti-pPAK1(T423)/pPAK2(T402)
antibody was from Cell Signaling Technology (MA) (Cat. # 2601S).
Protein Purification
GST-tagged intracellular domain of GC-E (GST-GC-E-intra) was puri-
fied from E. coli. His-tagged GC-E-intra protein was purified from High-
Five insect cells (Invitrogen). Baculoviruses containing GST-PAK1,
GST-PAK2, GST-PAK1(K298A), GST-PAK2(K278A), GST-PAK1-
KD(K298A), and GST-PAK1(K298A/T423E) were amplified in Sf9 cells
and then used to infect 2 l of High-Five cells. The GST-tagged protein
was purified using glutathione beads, followed by a Sephadex G-200
column (Pharmacia). His-tagged Rac1 was purified from E. coli using
Ni-NTA beads (Qiagen). Rac1 was activated by incubating with
100 mM of GTPgS in the loading buffer (20 mM Tris, pH 8, 100 mM
NaCl, 0.2 mM DTT, 1 mM EDTA) for 10 min at 30C.
GST Pull-Down Assay
GST pull-down assays were done as previously described with purified
proteins or with baculovirus-infected Sf9 cell lysates (Lowry et al.,
2002; Ma et al., 2000).
Guanylyl Cyclase Activity Assay
In vivo cGMP concentrations were determined from cell lysates with
the Direct cGMP Assay Kit from Assay Designs, Inc. In general, cells
were incubated for 18–24 hr after transfection before the medium
was changed to serum-free medium. Transfection efficiency of CHO
cells was 90% based on transfection with a GFP plasmid. After 24
hr of starvation, cells were incubated with 0.5 mM IBMX for 30 min.
Cells were washed once with ice-cold 1X PBS and lysed in 0.5% Triton
X-100 containing 0.5 mM IBMX. We empirically determined the dilution
factor for each cell lysate so that the experimental readings fall in the
middle of the linear standard curve of the Direct cGMP Assay Kit.
For the in vitro guanylyl cyclase activity assay, purified proteins were
mixed in 50 ml of reaction buffer (50 mM Hepes, pH 7.5, 100 mM NaCl,
10 mM MgCl2, 1 mM DTT, 1 mM GTP) and incubated for 20 min at
30C. GTP was added last to start the reaction (there was no detergentin these reactions). The reaction was terminated by adding HCl to a fi-
nal concentration of 0.1 M. The mixture was diluted 5- to 10-fold in 0.1
M HCl, and the cGMP content was determined with the Direct cGMP
Assay Kit from Assay Designs, Inc.
RNA Interference
RNAi of GC-A was performed in MEF cells with Qiagen’s HiPerform-
ance 2-for-Silencing siRNA duplexes. The target sequence for the first
siRNA was CCGGACCACTACACCAAGCTA. There are six nucleotide
differences between human and mouse GC-A in this region. The target
sequence for the second siRNA was AACGCATTGAGTTGACACGAA.
siRNA and Oligofectamine were diluted and mixed in OptiMEM I (Invi-
trogen) to allow the formation of siRNA-liposome complexes. After
a 20 min incubation at room temperature, the mixture was overlayed
onto MEF cells (50% confluent) cultured in medium without antibiotics.
The transfected cells were analyzed 72–96 hr after transfection.
In Vitro Phosphorylation Assay
Phosphorylation assay was done as previously described (Wan et al.,
1996).
Wound-Healing Assays and Chamber Assay
In vitro wound-healing assays and Boyden chamber assays were per-
formed as previously described (Shan et al., 2005; Yang and Huang,
2005).
Fluorescence Microscopy
Fluorescence microscopy was done as previously described (Lowry
et al., 2002).
MTOC Reorientation
MTOC reorientation (cell polarization) was analyzed as previously de-
scribed (Etienne-Manneville and Hall, 2001). MTOCs were labeled with
anti-pericentrin antibodies. Cells in which the MTOC was within the
quadrant facing the wound were scored positive, and for each condi-
tion, at least 100 cells were examined.
Supplemental Data
Supplemental Data include three figures, Supplemental Experimental
Procedures, Supplemental References, and three movies and can be
found with this article online at http://www.cell.com/cgi/content/full/
128/2/341/DC1/.
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